Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NCF1 | P14598 | 6/20 | 0.40 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.39 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
| ▸ | HTR7 | P34969 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | ACP1 | P24666 | 1/20 | 0.36 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9804066 | 0.81 | KCNA3 (0.51) | HTR7KDM4E | |
| SCHEMBL9804149 | 0.80 | NCF1 (0.38) | NCF1HTR1AHTR7ACP1GRM4 | |
| SCHEMBL10515224 | 0.78 | LMNA (0.41) | CYP1A2KDM4E | |
| SCHEMBL9804018 | 0.76 | NCF1 (0.42) | NCF1HTR1ACYP1A2 | |
| SCHEMBL9803998 | 0.75 | MEN1 (0.46) | NCF1CYP1A2KDM4E | |
| SCHEMBL9803996 | 0.75 | DRD3 (0.46) | KDM4E | |
| SCHEMBL9804044 | 0.73 | NCF1 (0.41) | NCF1CYP1A2 | |
| SCHEMBL16248312 | 0.73 | NCF1 (0.51) | NCF1HTR1ACYP1A2 | |
| SCHEMBL9804045 | 0.73 | NCF1 (0.43) | NCF1CYP1A2ACP1 | |
| SCHEMBL9804082 | 0.72 | BDKRB2 (0.39) | NCF1HTR1AHTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5026848-A | Antirhinovirus agents | SYNPHAR LABORATORIES INCORPORATED (CA) | 1991-06-25 | — | — | US | claimed |
| US-5026848-A | Antirhinovirus agents | SYNPHAR LABORATORIES INCORPORATED (CA) | 1991-06-25 | — | — | US | disclosed |
| EP-0335636-A1 | Antiviral compounds | SYNPHAR LABORATORIES INC. (CA) | 1989-10-04 | — | — | EP | disclosed |